Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1)

SIMPLE SUMMARY: Neurofibromatosis type 1 (Nf1) is a genetically determined neurodevelopmental disorder and tumor syndrome with an incidence of approximately 1/3000 live births. It is caused by loss of function mutations in the neurofibromin gene (Nf1) and is estimated to affect 100,000 people in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Joseph B., Raber, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526845/
https://www.ncbi.nlm.nih.gov/pubmed/37760547
http://dx.doi.org/10.3390/cancers15184579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526845/
https://www.ncbi.nlm.nih.gov/pubmed/37760547
http://dx.doi.org/10.3390/cancers15184579

Ejemplares similares